Nuvation Bio
Maryam Ahmadi, Ph.D., is an experienced professional in the field of CMC Regulatory Affairs, currently serving as the Head of CMC Regulatory Affairs at Nuvation Bio. Prior to this role, Maryam held the position of Head of CMC Regulatory Affairs at BioXcel Therapeutics, Inc. and served as the Senior Director of CMC Regulatory Affairs at EyePoint Pharmaceuticals. Earlier in Maryam's career, a role as Director of Quality Control at PLIVA contributed to a strong foundation in quality management within the pharmaceutical industry.
This person is not in any teams
This person is not in any offices
Nuvation Bio
2 followers
Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.